Acta Neuropathol

1. ANDO K, Kucukali F, Doeraene E, Nagaraj S, et al
   Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.
   Acta Neuropathol. 2024;147:94.
   

   >> Share

   
   

   
   Alzheimers Dement

2. ARBER C, Belder CRS, Tomczuk F, Gabriele R, et al
   The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Abeta43 and atypical clinical manifestations.
   Alzheimers Dement. 2024 Jun 2. doi: 10.1002/alz.13904.
   

   >> Share

   
   
3. LIU ZT, Liu MH, Xiong Y, Wang YJ, et al
   Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives.
   Alzheimers Dement. 2024 Jun 2. doi: 10.1002/alz.13864.
   

   >> Share

   
   
4. GUPTARAK J, Scaduto P, Tumurbaatar B, Zhang WR, et al
   Cognitive integrity in Non-Demented Individuals with Alzheimer's Neuropathology is associated with preservation and remodeling of dendritic spines.
   Alzheimers Dement. 2024 Jun 3. doi: 10.1002/alz.13900.
   

   >> Share

   
   
5. SIRKIS DW, Warly Solsberg C, Johnson TP, Bonham LW, et al
   Expansion of highly interferon-responsive T cells in early-onset Alzheimer's disease.
   Alzheimers Dement. 2024 Jun 3. doi: 10.1002/alz.13892.
   

   >> Share

   
   
6. YERRAMALLA MS, Darin-Mattsson A, Udeh-Momoh CT, Holleman J, et al
   Cognitive reserve, cortisol, and Alzheimer's disease biomarkers: A memory clinic study.
   Alzheimers Dement. 2024 Jun 4. doi: 10.1002/alz.13866.
   

   >> Share

   
   

   
   BMC Geriatr

7. XU B, Ling Y, Liu L, Liu Y, et al
   Potential prognostic value of CSF-targeted proteomics across the Alzheimer's disease continuum.
   BMC Geriatr. 2024;24:501.
   

   >> Share

   
   
8. YUAN Y, Yang Y, Hu X, Zhang L, et al
   Effective dosage and mode of exercise for enhancing cognitive function in Alzheimer's disease and dementia: a systematic review and Bayesian Model-Based Network Meta-analysis of RCTs.
   BMC Geriatr. 2024;24:480.
   

   >> Share

   
   

   
   Brain

9. COOMANS EM, Ossenkoppele R
   The implications of amyloid-beta pathology: only time will tell.
   Brain. 2024;147:1934-1936.
   

   >> Share

   
   

   
   Curr Alzheimer Res

10. MALEKI SF, Yousefi M, Sobhi N, Jafarizadeh A, et al
    Artificial Intelligence in Eye Movements Analysis for Alzheimer's Disease Early Diagnosis.
    Curr Alzheimer Res. 2024 Jun 4. doi: 10.2174/0115672050322607240529075641.
    

    >> Share

    
    

    
    Exp Gerontol

11. SAFARZADEH E, Ataei S, Akbari M, Abolhasani R, et al
    Quercetin ameliorates cognitive deficit, expression of amyloid precursor gene, and pro-inflammatory cytokines in an experimental models of Alzheimer's disease in Wistar rats.
    Exp Gerontol. 2024;193:112466.
    

    >> Share

    
    

    
    Exp Neurol

12. HUANG XY, Xue LL, Ma RF, Shi JS, et al
    Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment.
    Exp Neurol. 2024 May 29:114841. doi: 10.1016/j.expneurol.2024.114841.
    

    >> Share

    
    

    
    J Neurosci

13. TOSI G, Nigro S, Urso D, Spinosa V, et al
    The network structure of cognitive impairment: from Subjective Cognitive Decline to Alzheimer's Disease.
    J Neurosci. 2024 Jun 3:e1344232023. doi: 10.1523/JNEUROSCI.1344-23.2023.
    

    >> Share

    
    
14. ETXEBERRIA A, Shen YA, Vito S, Silverman S, et al
    Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis.
    J Neurosci. 2024 Jun 3:e2347232024. doi: 10.1523/JNEUROSCI.2347-23.2024.
    

    >> Share

    
    

    
    Nat Neurosci

15. BENJAMIN KJM, Chen Q, Eagles NJ, Huuki-Myers LA, et al
    Analysis of gene expression in the postmortem brain of neurotypical Black Americans reveals contributions of genetic ancestry.
    Nat Neurosci. 2024;27:1064-1074.
    

    >> Share

    
    

    
    Nat Rev Neurol

16. WOOD H
    Microglial senescence is a potential therapeutic target for Alzheimer disease.
    Nat Rev Neurol. 2024 Jun 4. doi: 10.1038/s41582-024-00979.
    

    >> Share

    
    
17. FYFE I
    APOE alpha4 homozygosity - a genetic form of Alzheimer disease?
    Nat Rev Neurol. 2024 Jun 4. doi: 10.1038/s41582-024-00985.
    

    >> Share

    
    

    
    Neurobiol Aging

18. KNUDTZON SL, Nordengen K, Grontvedt GR, Jarholm J, et al
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
    Neurobiol Aging. 2024;141:74-84.
    

    >> Share

    
    
19. BERNOCCHI F, Bonomi CG, Assogna M, Moreschini A, et al
    Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer's disease.
    Neurobiol Aging. 2024;141:66-73.
    

    >> Share

    
    

    
    Neurochem Res

20. GAYGER-DIAS V, Menezes L, Da Silva VF, Stiborski A, et al
    Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia.
    Neurochem Res. 2024;49:1851-1862.
    

    >> Share

    
    
21. WANG XF, Xiang XH, Wei J, Zhang PB, et al
    Raddeanin A Protects the BRB Through Inhibiting Inflammation and Apoptosis in the Retina of Alzheimer's Disease.
    Neurochem Res. 2024 Jun 4. doi: 10.1007/s11064-024-04145.
    

    >> Share

    
    
22. SHENG L, Bhalla R
    Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.
    Neurochem Res. 2024 Jun 6. doi: 10.1007/s11064-024-04178.
    

    >> Share

    
    

    
    Neurol Clin Pract

23. HANCOCK LM, Galioto R, Rhoads T, Ontaneda D, et al
    Comparing Cognitive Profiles in Older Adults With Multiple Sclerosis and Alzheimer Disease: More Similarities Than Differences.
    Neurol Clin Pract. 2024;14:e200327.
    

    >> Share

    
    

    
    Neurology

24. BOLSEWIG K, van Unnik AAJM, Blujdea ER, Gonzalez MC, et al
    Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
    Neurology. 2024;102:e209418.
    

    >> Share

    
    
25. SUN M, He Q, Sun N, Han Q, et al
    Intrinsic Capacity, Polygenic Risk Score, APOE Genotype, and Risk of Dementia: A Prospective Cohort Study Based on the UK Biobank.
    Neurology. 2024;102:e209452.
    

    >> Share

    
    

    
    PLoS One

26. LOPES DA CUNHA P, Ruiz F, Ferrante F, Sterpin LF, et al
    Automated free speech analysis reveals distinct markers of Alzheimer's and frontotemporal dementia.
    PLoS One. 2024;19:e0304272.
    

    >> Share

    
    
27. DENKINGER M, Baker S, Inglis B, Kobayashi S, et al
    Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults.
    PLoS One. 2024;19:e0299764.
    

    >> Share

    
    
28. AZMAL M, Hossen MS, Shohan MNH, Taqui R, et al
    A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
    PLoS One. 2024;19:e0304490.
    

    >> Share

    
    

    
    Science

29. TOPOL EJ
    Medical forecasting.
    Science. 2024;384:eadp7977.
    

    >> Share

    
    
30. PILLER C
    Authors move to retract discredited Alzheimer's study.
    Science. 2024;384:1055.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share